US PATENT SUBCLASS 424 / 181.1
.~.~ Conjugated to nonproteinaceous bioaffecting compound (e.g., conjugated to cancer-treating drug, etc.)

Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use


424 /   HD   DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS

178.1  DF  CONJUGATE OR COMPLEX OF MONOCLONAL OR POLYCLONAL ANTIBODY, IMMUNOGLOBULIN, OR FRAGMENT THEREOF WITH NONIMMUNOGLOBULIN MATERIAL {3}
179.1  DF  .~ Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.) {2}
181.1.~.~ Conjugated to nonproteinaceous bioaffecting compound (e.g., conjugated to cancer-treating drug, etc.)

DEFINITION

Classification: 424/181.1

Conjugated to nonproteinaceous bioaffecting compound (e.g., conjugated to cancer-treating drug, etc.):

(under subclass 179.1) Subject matter wherein the nonimmunoglobulin material is a nonproteinaceous bioaffecting compound, such as a nonproteinaceous drug (e.g., a cancer-treating drug).